Krzysztof Strojek

Summary

Affiliation: Medical University of Silesia
Country: Poland

Publications

  1. ncbi Is there an impact of treatment with DPP-4 inhibitors on lymphocyte subpopulations in type 2 diabetic patients?
    Krzysztof Strojek
    Endokrynol Pol 65:78-82. 2014
  2. doi [Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride]
    K Strojek
    Department of Internal Diseases, Diabetology and Nephrology, Silesian Medical University, Zabrze, Polen
    Dtsch Med Wochenschr 138:S16-26. 2013
  3. doi Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
    Krzysztof Strojek
    Department of Internal Diseases Diabetology and Nephrology, Silesian Medical University, Zabrze, Poland
    Curr Med Res Opin 25:2887-94. 2009
  4. doi Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial
    K Strojek
    Department of Internal Diseases, Diabetology and Nephrology, Silesian Medical University, Zabrze, Poland
    Diabetes Obes Metab 13:928-38. 2011
  5. pmc The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively
    Michal Mazurek
    Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Center for Heart Diseases, ul, Szpitalna 2, 41 800, Zabrze, Poland
    Cardiovasc Diabetol 11:78. 2012
  6. ncbi Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention
    Damian Pres
    Department of Cardiology, Silesian Medical University, Zabrze, Poland
    Kardiol Pol 68:743-51. 2010
  7. ncbi Salt-sensitive blood pressure--an intermediate phenotype predisposing to diabetic nephropathy?
    Krzysztof Strojek
    Department of Internal Diseases, Diabetology and Nephrology, Silesian Medical Academy, 3 go Maja 13 15, Zabrze 41 800, Poland
    Nephrol Dial Transplant 20:2113-9. 2005
  8. doi Self-monitoring of blood glucose in treatment of type 2 diabetes
    Aleksandra Szymborska-Kajanek
    Department of Internal Diseases Diabetology and Nephrology, Silesian Medical University, Zabrze, Poland
    Diabetes Res Clin Pract 86:S49-52. 2009
  9. doi Impact of low-frequency pulsed magnetic fields on defensin and CRP concentrations in patients with painful diabetic polyneuropathy and in healthy subjects
    Aleksandra Szymborska-Kajanek
    Diabetological Unit of the Department of Internal Medicine, Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland
    Electromagn Biol Med 29:19-25. 2010
  10. ncbi Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function
    Jacek Kowalczyk
    Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland
    Med Sci Monit 16:CR67-74. 2010

Detail Information

Publications12

  1. ncbi Is there an impact of treatment with DPP-4 inhibitors on lymphocyte subpopulations in type 2 diabetic patients?
    Krzysztof Strojek
    Endokrynol Pol 65:78-82. 2014
    ..The aim was to assess lymphocyte subpopulations initially and after 14 days of treatment with DPP-4 inhibitors sitagliptin, saxagliptin and vildagliptin...
  2. doi [Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride]
    K Strojek
    Department of Internal Diseases, Diabetology and Nephrology, Silesian Medical University, Zabrze, Polen
    Dtsch Med Wochenschr 138:S16-26. 2013
    ..We assessed the efficacy, safety and tolerability of dapagliflozin added to glimepiride in patients with uncontrolled T2DM...
  3. doi Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
    Krzysztof Strojek
    Department of Internal Diseases Diabetology and Nephrology, Silesian Medical University, Zabrze, Poland
    Curr Med Res Opin 25:2887-94. 2009
    ..To assess the efficacy and safety of biphasic insulin aspart 70/30 (BIAsp 30) and insulin glargine, administered once daily in subjects with type 2 diabetes inadequately controlled with oral anti-diabetic drugs...
  4. doi Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial
    K Strojek
    Department of Internal Diseases, Diabetology and Nephrology, Silesian Medical University, Zabrze, Poland
    Diabetes Obes Metab 13:928-38. 2011
    ..We assessed the efficacy, safety and tolerability of dapagliflozin added to glimepiride in patients with uncontrolled T2DM...
  5. pmc The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively
    Michal Mazurek
    Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Center for Heart Diseases, ul, Szpitalna 2, 41 800, Zabrze, Poland
    Cardiovasc Diabetol 11:78. 2012
    ..However, the prognostic value of different glucose abnormalities (GA) other than DM in subjects with acute myocardial infarction (AMI) treated invasively remains unclear...
  6. ncbi Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention
    Damian Pres
    Department of Cardiology, Silesian Medical University, Zabrze, Poland
    Kardiol Pol 68:743-51. 2010
    ..There are only a few reports on the relationship between glycaemia in the acute phase of MI complicated by cardiogenic shock (CS) and prognosis...
  7. ncbi Salt-sensitive blood pressure--an intermediate phenotype predisposing to diabetic nephropathy?
    Krzysztof Strojek
    Department of Internal Diseases, Diabetology and Nephrology, Silesian Medical Academy, 3 go Maja 13 15, Zabrze 41 800, Poland
    Nephrol Dial Transplant 20:2113-9. 2005
    ..Family studies point to important genetic determinants of diabetic nephropathy (DN). Blood pressure (BP) is higher in offspring of patients with type 2 diabetes and DN, but the pathomechanisms involved have not been elucidated...
  8. doi Self-monitoring of blood glucose in treatment of type 2 diabetes
    Aleksandra Szymborska-Kajanek
    Department of Internal Diseases Diabetology and Nephrology, Silesian Medical University, Zabrze, Poland
    Diabetes Res Clin Pract 86:S49-52. 2009
    ....
  9. doi Impact of low-frequency pulsed magnetic fields on defensin and CRP concentrations in patients with painful diabetic polyneuropathy and in healthy subjects
    Aleksandra Szymborska-Kajanek
    Diabetological Unit of the Department of Internal Medicine, Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland
    Electromagn Biol Med 29:19-25. 2010
    ..The aim was to assess whether magnetic field influences defensin and CRP concentrations in patients with diabetic polyneuropathy and in healthy subjects...
  10. ncbi Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function
    Jacek Kowalczyk
    Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland
    Med Sci Monit 16:CR67-74. 2010
    ..The aim of the study was to evaluate the impact of DM with and without CKD on prognosis in patients with acute myocardial infarction (AMI) treated invasively...
  11. ncbi Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects
    Marcin J Zychma
    Department and Clinic of Internal Medicine and Diabetology, Silesian Medical University, Zabrze, Poland
    Med Sci Monit 8:CR512-5. 2002
    ....
  12. ncbi Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention
    Mariusz Gasior
    Department of Cardiology, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland
    Cardiol J 15:422-30. 2008
    ..We sought to assess the influence of blood glucose levels on admission on prognosis of patients with acute ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI)...